Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-08

Clinical Trial Update: Laser Ablation of Papillary Thyroid Microcarcinoma [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study of laser ablation for papillary thyroid microcarcinoma, sponsored by Memorial Sloan Kettering Cancer Center…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Papillary Thyroid Microcarcinoma, Thyroid | Phase 2 | Status: ACTIVE_NOT_RECRUITING